NewsOur news BioVersys in the NewsBioversys AG and Aptuit Announce Collaboration to Identify Novel Approaches to Treat Serious Infections from Gram-Negative PathogensBioVersys in the NewsMarc Gitzinger wins innovation prize for BioVersys AG 123…56Next »
BioVersys in the NewsBioversys AG and Aptuit Announce Collaboration to Identify Novel Approaches to Treat Serious Infections from Gram-Negative Pathogens